Target intelligence / Profile preview

Immunoglobulin heavy diversity 6-13 (IGHD6-13)

Target
IGHD6-13
Molecular classification
Immunoglobulin diversity gene, Other (genomic segment, not a protein product or molecular target)
01

Overview

Immunoglobulin heavy diversity 6-13 (IGHD6-13) is a gene segment within the immunoglobulin heavy chain locus on human chromosome 14q32[5]. It falls within the "D" (diversity) segment class, which, together with V (variable) and J (joining) gene segments, undergoes somatic rearrangement during B-cell development to create the variable region of the antibody heavy chain, specifically contributing nucleotides to the hypervariable region CDR3[2][3]. This process allows the immune system to generate a vast antibody repertoire using a limited number of inherited gene segments[2][4]. IGHD segments themselves are not functional receptors, proteins, or therapeutic targets; rather, their rearrangement is necessary for the generation of functional immunoglobulin molecules. IGHD6-13 is one of many "D" gene segments, each providing genetic diversity crucial for immune recognition, but not known to be independently associated with specific diseases or targeted by drugs. Key points: - IGHD6-13 is not a standalone therapeutic target or receptor[2][3]. - Errors in naming and duplication in aliases ("DN1, DN1, IGHD613, IGHD6-13") indicate inconsistent use and potential mistakes in database entry[3]. - Its biological significance is limited to its contribution to immunoglobulin gene rearrangement and antibody diversity[2][4][5].

Other names
IGHD6-13IGHD613DN1
02

Biological functions

Generation of antibody diversityImmune response (indirect, via contribution to variable regions of antibodies)
03

Disease associations

Other (Not directly implicated in disease; disruptions in immunoglobulin gene recombination can affect immune diversity, but IGHD segments are not individually linked to specific diseases)

Beyond the preview

Go deeper on Immunoglobulin heavy diversity 6-13 (IGHD6-13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy diversity 6-13 (IGHD6-13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call